Safety and efficacy of a recombinant yeast-derived pre-S2 + S-containing hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples